News

The four-year observational study will research U.S. pregnant people with cardiovascular disease to better understand and combat maternal mortality and morbidity.

A new subanalysis presented by Dr. Mikhail Kosiborod shows benefits of semaglutide in patients with atrial fibrillation.

FOX4 talked to Dr. Tracy Stevens about how women have been underrepresented in cardiovascular research and how the new institute plans to make a difference.

This week, we’re talking about hypertension in younger women and the importance of knowing and staying on top of your blood pressure.

MedCity News talked to Dr. Sanjaya Gupta, cardiologist at Saint Luke's Mid America Heart Institue, about how the new virtual program to help patients with atrial fibrillation came to be.

The new, co-developed a-fib program delivers holistic care that magnifies specialty providers’ ability to see more patients and improve their quality of life.

During Heart Month, we are talking about atrial fibrillation, the recent changes in guidelines, and how Saint Luke’s is leading the way in innovative treatments for those who have a-fib.

Dr. Tracy Stevens talks to KCTV about the unique symptoms of heart attacks in women and what people can do today to lower their risk of heart disease.

Dr. Tracy Stevens shares how heart disease affects women uniquely and why more advocacy and research is needed on women's hearts.

Saint Luke’s Mid America Heart Institute was the first in Kansas and Missouri, and one of only 27 US institutions, to participate in PULSED AF clinical trial.